What Researchers Did
Researchers conducted a retrospective study on 14 patients with chronic refractory osteomyelitis of the tibias to evaluate the clinical results of hyperbaric oxygen (HBO) therapy combined with debridement and antibiotics.
What They Found
Patients underwent an average of 5.4 operations before HBO therapy and received an average of 33.6 HBO treatments. Following treatment, 11 out of 14 patients (79%) experienced no recurrence of infection, indicating a high success rate.
What This Means for Canadian Patients
Hyperbaric oxygen therapy, when combined with standard treatments like debridement and antibiotics, could offer a promising option for Canadian patients suffering from chronic refractory osteomyelitis. This approach may help reduce infection recurrence and improve outcomes for those with difficult-to-treat bone infections.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in Taiwan.
Study Limitations
This was a retrospective study with a small sample size of 14 patients, limiting the generalizability and strength of the evidence.